Ray Dalio’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-32,926
Closed -$475K 950
2024
Q1
$475K Sell
32,926
-4,907
-13% -$81.1K ﹤0.01% 629
2023
Q4
$814K Sell
37,833
-4,434
-10% -$79.1K ﹤0.01% 660
2023
Q3
$812K Buy
42,267
+3,996
+10% +$85.2K ﹤0.01% 637
2023
Q2
$973K Sell
38,271
-4,230
-10% -$122K 0.01% 580
2023
Q1
$1.54M Buy
42,501
+1,566
+4% +$55K 0.01% 504
2022
Q4
$1.62M Sell
40,935
-13,980
-25% -$581K 0.01% 564
2022
Q3
$2.56M Buy
54,915
+105
+0.2% +$4.87K 0.01% 510
2022
Q2
$2.4M Buy
54,810
+6,075
+12% +$334K 0.01% 641
2022
Q1
$3.52M Buy
48,735
+11,643
+31% +$839K 0.01% 548
2021
Q4
$3.01M Buy
37,092
+4,758
+15% +$477K 0.02% 401
2021
Q3
$3.76M Sell
32,334
-2,439
-7% -$319K 0.02% 334
2021
Q2
$5.76M Buy
+34,773
New +$5.43M 0.04% 310

Other funds holding NVRO

Ray Dalio's NVRO Position: Q2 2024 in Review

Ray Dalio sold out of NEVRO CORP. (NVRO) in Q2 2024, closing a stake of 32,926 shares — an estimated $475K sold.

Ray Dalio first reported a position in NVRO in Q2 2021 and held it in 12 quarters. The position peaked at $5.76M in Q2 2021. 152 funds tracked by Wall St. Rank hold NVRO as of Q2 2024.

  • Ray Dalio reported no remaining NEVRO CORP. position as of Q2 2024 after selling out during the quarter.
  • Ray Dalio sold 32,926 NEVRO CORP. shares in Q2 2024, an estimated $475K.
  • Ray Dalio first reported a position in NEVRO CORP. in Q2 2021 and held it in 12 quarters.
  • Ray Dalio's NEVRO CORP. position peaked at $5.76M in Q2 2021.
  • 152 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2024.

Based on Bridgewater Associates's 13F filing for Q2 2024, filed 14 Aug 2024.